Wellthy Therapeutics appoints Vasudev V Tribhuvan as VP, Partnerships & Alliances

Tribhuvan is an alumni of the University of California, Los Angeles

Wellthy Therapeutics (Wellthy) announced the appointment of Vasudev V Tribhuvan as Vice President, Partnerships & Alliances effective May 2018.

Tribhuvan’s previous role was at Biocon, where he was the Senior Director, Marketing and led strategic initiatives for the metabolic unit while guiding the team on patient programmes. Prior to Biocon, Tribhuvan held sales and marketing leadership roles with AstraZeneca, Boehringer Ingelheim and Novo Nordisk, and is an alumni of the University of California, Los Angeles.

Commenting on his new role, Tribhuvan said, “For years, there has been a push within the pharmaceutical industry to move ‘beyond the pill’, to improve outcomes in chronic metabolic disorders. The impetus to move beyond the pill typically arises from the realisations that drugs alone do not suffice for patients to achieve optimal clinical outcomes. Pharma companies should consider integrating beyond-the-pill solutions as a differentiated package offering in chronic disease categories, also ensuring better outcomes.”